Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ashley Cantu-Weinstein
Observed names:
Ashley Cantu‐Weinstein,
Cantu-Weinstein, Ashley
Institution:
Natera (United States)
Observed institution:
Natera (United States)
OpenAlex ID:
A5123411236
Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants
2025
·
Vivienne Souter
, Lisa Johnson
, et al.
·
Journal of Genetic Counseling
·
3
PDF
Ultrasound and SNP-based cell-free DNA zygosity testing in twin pregnancies
2026
·
Ruben Quintero
, K. Joseph Hurt
, et al.
·
The Journal of Maternal-Fetal & Neonatal Medicine
·
1
PDF
Reproductive Carrier Screening Detects Early Actionable Metabolic Conditions
2026
·
Christian M. Parobek
, Roni Zemet
, et al.
·
Genetics in Medicine
Testing for hereditary cancer genes in men: a missed opportunity for cancer prevention
2026
·
Calan Szmyd
, Madison LaFleur
, et al.
·
Frontiers in Oncology
PDF
Ultrasound and SNP-based cell-free DNA zygosity testing in twin pregnancies
2026
·
Quintero, Ruben
, Hurt, K. Joseph
, et al.
·
Figshare
P743: Fetal chimerism identified following SNP-based prenatal cell-free DNA screening
2026
·
Ping Gong
, Peter Benn
, et al.
·
Genetics in Medicine Open
PDF
P712: Identification of suspected bone marrow transplantation in prenatal cell-free DNA screening using SNP-based profiling*
2026
·
India Bradley
, Kristen Young
, et al.
·
Genetics in Medicine Open
P728: A comparison of the performance of reproductive carrier screening based on the ACMG tier 3 panel versus current ACOG recommendations
2026
·
Vivienne Souter
, Victoria Blank
, et al.
·
Genetics in Medicine Open
PDF
O63: Reproductive carrier screening for metabolic conditions with heterozygous manifestations
2026
·
Christian Parobek
, Roni Zemet Lazar
, et al.
·
Genetics in Medicine Open
PDF
O60: AFF2 gene variants identified through carrier screening for Fragile XE syndrome
2025
·
Lisa Johnson
, Lauren Tuttle
, et al.
·
Genetics in Medicine Open
PDF
P214: Inequities in eligibility for cystic fibrosis modulator therapy based on pathogenic/likely pathogenic CFTR gene variants identified through carrier screening
2025
·
Erin Armenti
, Ashley Cantu-Weinstein
, et al.
·
Genetics in Medicine Open
PDF
Show more works
View as search
Works count:
11
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type